These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36465641)

  • 1. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study.
    Auchus RJ; Courtillot C; Dobs A; El-Maouche D; Falhammar H; Lacroix A; Farrar M; O'Donoghue C; Anatchkova M; Cutts K; Taylor N; Yonan C; Lamotte M; Touraine P
    Front Endocrinol (Lausanne); 2022; 13():1005963. PubMed ID: 36465641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM; Stepien KM; Krishan A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
    Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term morbidity in congenital adrenal hyperplasia].
    Tschaidse L; Quitter F; Hübner A; Reisch N
    Internist (Berl); 2022 Jan; 63(1):43-50. PubMed ID: 34978615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
    Liu SC; Suresh M; Jaber M; Mercado Munoz Y; Sarafoglou K
    Front Endocrinol (Lausanne); 2023; 14():1101843. PubMed ID: 36936152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 46,XX males with congenital adrenal hyperplasia: a clinical and biochemical description.
    Adriaansen BPH; Utari A; Westra D; Juniarto AZ; Ariani MD; Ediati A; Schröder MAM; Span PN; Sweep FCGJ; Drop SLS; Faradz SMH; van Herwaarden AE; Claahsen-van der Grinten HL
    Front Endocrinol (Lausanne); 2024; 15():1410122. PubMed ID: 39175568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
    Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.
    Adriaansen BPH; Schröder MAM; Span PN; Sweep FCGJ; van Herwaarden AE; Claahsen-van der Grinten HL
    Front Endocrinol (Lausanne); 2022; 13():1064024. PubMed ID: 36578966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
    Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V
    Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country.
    Utari A; Faradz SMH; Ediati A; Rinne T; Ariani MD; Juniarto AZ; Drop SLS; van Herwaarden AE; Claahsen-van der Grinten HL
    Front Endocrinol (Lausanne); 2022; 13():1015973. PubMed ID: 36589846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia.
    Kamrath C; Hartmann MF; Pons-Kühnemann J; Wudy SA
    Metabolism; 2020 Nov; 112():154354. PubMed ID: 32916150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
    Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
    Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Merke DP
    J Clin Endocrinol Metab; 2008 Mar; 93(3):653-60. PubMed ID: 18326005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
    Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
    Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management challenges and therapeutic advances in congenital adrenal hyperplasia.
    Mallappa A; Merke DP
    Nat Rev Endocrinol; 2022 Jun; 18(6):337-352. PubMed ID: 35411073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classic congenital adrenal hyperplasia and puberty.
    Charmandari E; Brook CG; Hindmarsh PC
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U77-82. PubMed ID: 15554890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
    Kamrath C; Friedrich C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2023 Jul; 231():106304. PubMed ID: 36990162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.